Pacira BioSciences, Inc. (PCRX) CEO Dave Stack on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/04/21
Pacira BioSciences Reports First Quarter 2021 Financial Results and Business UpdateGlobeNewsWire • 05/04/21
Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/29/21
Flexion Therapeutics Announces Presentation of Preliminary FX201 Clinical Data at the Upcoming 2021 American Society of Gene & Cell Therapy (ASGCT) Annual MeetingGlobeNewsWire • 04/28/21
Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in AnesthesiologyGlobeNewsWire • 04/14/21
Flexion Therapeutics Announces Preliminary First-Quarter 2021 Revenue and Provides Financial Guidance for 2021GlobeNewsWire • 04/13/21
Flexion Therapeutics to Present at the Needham 20th Annual Virtual Healthcare ConferenceGlobeNewsWire • 04/08/21
Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021GlobeNewsWire • 04/07/21
Flexion Therapeutics Announces First Patient Treated in FX301 Phase 1b Trial for Management of Post-Operative PainGlobeNewsWire • 03/31/21
Pacira (PCRX) Down 3.6% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/27/21
Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric PatientsGlobeNewsWire • 03/22/21
FDA Decisions For Pfizer, Eli Lilly And Bluebird Bio, Bristol-Meyers Squibb, Plus New Data And EarningsBenzinga • 03/20/21
Flexion Therapeutics to Present at the Oppenheimer 31st Annual Virtual Healthcare ConferenceGlobeNewsWire • 03/15/21
Flexion Therapeutics (FLXN) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/11/21
Flexion Therapeutics, Inc. (FLXN) CEO Michael Clayman on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/11/21
Flexion Therapeutics Reports Fourth-Quarter and Full-Year 2020 Financial ResultsGlobeNewsWire • 03/10/21
Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021GlobeNewsWire • 03/09/21
Will Flexion Therapeutics (FLXN) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 03/04/21